Primary study · included by 1 review

Double‐blind, placebo‐controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism

Mancini 2003 · Mancini Francesca, Zangaglia Roberta, Cristina Silvano, et al. · Movement Disorders · 2003

Trial PICO

Not extracted yet. Trial-level population, intervention, comparator, outcomes and design will appear here after the trial extraction run. Until then, the reviews below describe the study.

Results

Not extracted yet. Per-trial results (events, means, effect and weight as each review's forest plot reports them) will appear here after the trial extraction run.

Included by

The effectiveness and safety of botulinum toxin injections for the treatment of sialorrhea with Parkinson's disease: a systematic review and meta-analysis.

Non-Cochrane · intervention · 2023 · cited as Mancini 2003 · Table 1; Ref [40] (Mov Disord 2003); DSFS (Fig. 4, BoNt-A) and adverse events (Fig. 6, BoNt-A)

The review does not say which of its outcomes this study informs.

1 including review in total.